Approval · Notice of Compliance 12781 · 2011
CERTICAN: Notice of Compliance 12781
Issued November 14, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12781
- Date
- November 14, 2011
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Immunosuppressant
Products in this notice
Medicinal ingredients
- EVEROLIMUS 0.25 MG per TAB
- EVEROLIMUS 0.5 MG per TAB
- EVEROLIMUS 0.75 MG per TAB